Medical Cannabis for Neuropathy: Studies and Findings
Explore the potential of medical cannabis in treating neuropathy, based on recent studies and findings.
Medical cannabis can reduce neuropathic pain for some patients, mainly with THC-containing products, but average relief is modest and the evidence is mixed. It is not FDA-approved for neuropathy and is not a first-line therapy. Most clinicians treat it as an add-on to standard options such as gabapentin, duloxetine, or topical lidocaine.
Neuropathy is nerve damage that causes numbness, tingling, burning, or shooting pain, often in the feet and hands. Common causes include diabetes, chemotherapy, HIV, alcohol use, and injury.
best strain for neuropathy medical cannabis
Cannabinoids such as THC and CBD interact with CB1 and CB2 receptors in the nervous system, which may dampen pain signaling. That mechanism is plausible, but real-world results vary by person, product, and dose.
A 2017 National Academies review found substantial evidence that cannabis or cannabinoids relieve chronic pain in adults, a category that includes neuropathic pain.
medical cannabis neuropathy treatment
Randomized trials of smoked cannabis and nabiximols, a THC-CBD oromucosal spray, show average pain drops of about 1 to 2 points on a 10-point scale. Some patients report far more relief, while others get none.
CBD has anti-inflammatory and possible pain-relieving effects, but trials for neuropathic pain are small and results are inconsistent. High-CBD, low-THC products are often tried first because they cause less impairment.
Start low and go slow. A common starting point is 1 to 2 mg of THC per dose, taken in the evening, with increases every few days until pain eases or side effects appear.
CBD doses in studies often range from 10 mg to 50 mg or more per day. Higher doses may need medical supervision, especially with liver disease or prescription drugs.
Inhaled products act within minutes, while oral oils and edibles take 1 to 3 hours and last longer. Topicals do not enter the bloodstream in meaningful amounts and will not make you high.
Do not drive after using THC. Avoid cannabis in pregnancy and during breastfeeding. Tell your clinician about every product you use, including hemp-derived ones.
Cannabis remains Schedule I under federal law, but most states run medical programs, and many list neuropathy or chronic pain as a qualifying condition. Hemp-derived CBD with no more than 0.3% THC is federally legal under the 2018 Farm Bill.
First-line drugs include gabapentin, pregabalin, duloxetine, venlafaxine, and tricyclic antidepressants such as amitriptyline. Topical lidocaine or capsaicin and physical therapy can also help. Tight blood sugar control keeps diabetic neuropathy from getting worse.
Cannabis may offer modest relief for nerve pain when standard drugs fall short. Use it as part of a supervised plan, pick products with known THC and CBD content, and watch for side effects.